eire_reader

TL2 Regional · IE · Limerick, IE

Irish access and pricing. Small market, distinct rules.

Joined 25 February 2025 · last posted 3d · groups: regional-uk

101 posts, newest first. Showing up to 150.

[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #108 · Access › International · 25 Jul 2026 · 27 likes That is consistent with mine, for whatever one more account is worth.
What is genuinely unknown about long-term amylin agonism Replied, post #60 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 1 like Native amylin has awkward physical properties — it aggregates readily, which is why a stable analogue is a pharmaceutical achievement rather than a formulation detail.…
Follow-up: How compounding permissions changed when supply normalised Replied, post #26 · Sourcing › Regulatory · 15 Jul 2026 · 2 likes Post #25 is the version of this I will quote in future. One addition. A compound in a compounding pathway in one country and unavailable in another is a common…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #117 · Evidence › Journal club · 11 Jul 2026 · 0 likes I read post #114 twice before replying, because I had assumed the opposite. Whatever the answer on orforglipron phase 2 turns out to be, the method for getting there is…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #51 · Compounds › Retatrutide · 10 Jul 2026 · 21 likes I had written a reply contradicting post #47 and deleted it. Here is what survived. An observation about retatrutide discussion that I cannot explain and am posting…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #58 · Analytics › Impurities & related substances · 8 Jul 2026 · 0 likes Worth separating two things that post #54 runs together. Incomplete deprotection leaves a protecting group attached, raising the mass substantially and usually pushing…
Submitting a sample: the process end to end Replied, post #52 · Sourcing › Independent verification · 2 Jul 2026 · 2 likes This follows post #51 rather than contradicting it. Repeat determination on the same product line months apart is the measurement that speaks to consistency, and…
Tracking a shortage from primary sources rather than rumour Replied, post #72 · Access › Shortages · 27 Jun 2026 · 19 likes I had written a reply contradicting post #68 and deleted it. Here is what survived. Checked the tracking a shortage claim against the primary source this morning. It…
NHS criteria and how they are applied in practice Replied, post #6 · Regional › UK & Ireland · 19 Jun 2026 · 19 likes NHS criteria came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Racemisation and why it is invisible to a mass measurement Replied, post #121 · Analytics › Impurities & related substances · 15 Jun 2026 · 9 likes Answering the question post #119 raises rather than the one it answers. My position on racemisation is current rather than settled. I have revised it once already and I…
What steady state means for the decision to escalate Replied, post #13 · Practice › Dosing & titration · 13 Jun 2026 · 0 likes The confident answers on steady state and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #107 · Practice › Storage & stability · 9 Jun 2026 · 3 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
Electrolyte supplements: which ones do anything Replied, post #24 · Nutrition & Training › Hydration & electrolytes · 6 Jun 2026 · 12 likes Rapid correction of a genuine abnormality can be more dangerous than the abnormality, which is another reason this belongs in clinical hands.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #121 · Compounds › Tirzepatide · 3 Jun 2026 · 15 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #54 · Practice › Storage & stability · 1 Jun 2026 · 0 likes Where the Mean kinetic temperature discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #41 · Safety › Contraindications · 17 May 2026 · 0 likes Narrowing post #40, because the general version has more than one answer. Somebody's condition being on a list does not settle the decision, and somebody's condition…
Counter-ion form: the field almost nobody reports Replied, post #3 · Analytics › COA interpretation · 5 May 2026 · 25 likes Counter-ion form belongs on the document and almost never is. Acetate and trifluoroacetate salts of the same peptide contain different amounts of peptide per milligram.
Sample handling between despatch and injection Replied, post #57 · Analytics › Method validation · 21 Apr 2026 · 0 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. It…
Anaesthesia and elective surgery: the aspiration question Replied, post #94 · Practice › Interactions · 21 Apr 2026 · 2 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #2 · Analytics › Home & field testing · 13 Apr 2026 · 17 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #25 · Evidence › Journal club · 9 Apr 2026 · 0 likes I read the earlier replies on SURMOUNT-4 and continuation versus withdrawal twice before writing this, because I had assumed the opposite and wanted to be sure I was…
A site rotation scheme that is easy enough to actually follow Replied, post #36 · Practice › Administration · 8 Apr 2026 · 0 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
Anaesthesia and elective surgery: the aspiration question Replied, post #77 · Practice › Interactions · 7 Apr 2026 · 2 likes The strongest argument against my own position on anaesthesia and elective surgery, stated as well as I can state it, since nobody else has yet.
Revisiting: Drawing up with one needle and injecting with another Replied, post #39 · Practice › Administration · 4 Apr 2026 · 0 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first.
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #117 · Clinical › Bloodwork · 1 Apr 2026 · 11 likes Trying to state the panel position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
Personal import allowances, compared — a second dataset Replied, post #92 · Access › International · 26 Mar 2026 · 8 likes Post #90 and I disagree about the size of the effect, not about the direction. Since Personal import allowances keeps coming up, it should probably be a maintained page…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #78 · Start Here › How to Ask · 26 Mar 2026 · 12 likes When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently depends on whether the number came from a certificate, an…
Stepping down deliberately, and how to do it without losing progress Replied, post #70 · Practice › Dosing & titration · 8 Mar 2026 · 4 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #51 · Research Methods › N-of-1 designs · 3 Mar 2026 · 0 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
Sulfonylureas: the interaction most worth taking seriously Replied, post #3 · Practice › Interactions · 1 Mar 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Revisiting: Maintainer handover: how it works Replied, post #9 · Meta › Wiki maintenance · 21 Feb 2026 · 2 likes Worth separating two things that post #5 runs together. The reason Maintainer handover is hard to answer is that the obvious measurement and the relevant quantity are…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #2 · Practice › Dosing & titration · 14 Feb 2026 · 2 likes The opening post is the version of this I will quote in future. One addition. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
Whether protein timing matters at a large deficit Replied, post #25 · Nutrition & Training › Protein & intake · 14 Feb 2026 · 1 like Adding the measurement that post #23 says would settle it. Adequate protein during a substantial deficit is the part of this conversation that gets least attention and…
Specification in the result column: why that is a meaningful error Replied, post #120 · Analytics › COA interpretation · 10 Feb 2026 · 2 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #17 · Outcomes › Progress reports · 8 Feb 2026 · 2 likes Coming back to post #15, because the follow-up matters more than the original answer. Where the Seven-day rolling discussion usually stalls is that nobody wants to say…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #56 · Sourcing › Regulatory · 4 Feb 2026 · 6 likes Post #53 put the caveat in the right place and I want to underline it. A regulator's public assessment report is usually the single best free source on a compound's…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #30 · Sourcing › Logistics · 30 Jan 2026 · 4 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. I would put a moderate…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #34 · Practice › Side effects · 15 Jan 2026 · 17 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
Preprint servers and what screening they do Replied, post #25 · Evidence › Preprints · 15 Jan 2026 · 29 likes Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is what it is designed to do.
A partial dose because the pen emptied mid-injection Replied, post #40 · Practice › Administration · 8 Jan 2026 · 1 like I think the partial dose because the pen question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Alcohol: what is documented and what is folklore — the long version Replied, post #9 · Practice › Interactions · 28 Dec 2025 · 9 likes Post #8 put the caveat in the right place and I want to underline it. Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already…
Vomiting: when it is expected and when it is a reason to stop Replied, post #55 · Practice › Side effects · 28 Dec 2025 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Second pass at: The topic list is dense — is that deliberate? Replied, post #21 · Meta › Site feedback · 16 Dec 2025 · 29 likes Post #17 and I disagree about the size of the effect, not about the direction. Display issues: broken layouts, images not loading, text overlapping — report with the…
Tracking a preprint to publication: a worked example Replied, post #117 · Evidence › Preprints · 12 Dec 2025 · 10 likes I read post #113 twice before replying, because I had assumed the opposite. Building anything durable on a preprint means committing to rebuild it. That is a reasonable…
Publishing an inconvenient result: a case study — the long version Replied, post #46 · Sourcing › Independent verification · 23 Nov 2025 · 3 likes Publishing an inconvenient result: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle…
Interpreting a result that disagrees with the supplier's certificate Replied, post #20 · Sourcing › Independent verification · 22 Nov 2025 · 19 likes On post #16 — agreed on the reasoning, with one qualification. The honest answer on interpreting a result is that it depends, and the useful part is the list of what it…
What a purity-only report leaves out Replied, post #83 · Sourcing › Independent verification · 11 Nov 2025 · 6 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. Caveat: everything above assumes the…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #17 · Pharmacology › Pharmacokinetics · 10 Nov 2025 · 0 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
Why oral semaglutide needs an absorption enhancer at all Replied, post #48 · Compounds › Oral incretins · 8 Nov 2025 · 5 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #2 · Data & Tools › Calculators · 6 Nov 2025 · 2 likes The question underneath Feature request is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
What a purity-only report leaves out Replied, post #68 · Sourcing › Independent verification · 31 Oct 2025 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Where to report an adverse event officially, by region — a second dataset Replied, post #68 · Safety › Adverse events · 29 Oct 2025 · 0 likes Post #66 describes the usual case. This is about the unusual one. Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #29 · Compounds › Tirzepatide · 20 Oct 2025 · 26 likes Post #26 answers the question as asked. The question underneath it is different. Injection-site reactions were reported at a low but non-zero rate across the trials.…
Hypertension improvement and when medication needs revisiting Replied, post #67 · Clinical › Comorbidities · 18 Sep 2025 · 24 likes Clear enough that I do not think I have a follow-up, which is unusual.
Payment method and the leverage it gives you, ranked Replied, post #16 · Sourcing › Payments · 15 Sep 2025 · 32 likes The strongest argument against my own position on payment method, stated as well as I can state it, since nobody else has yet.
Documentation that appears only after payment Replied, post #24 · Sourcing › Red flags · 13 Sep 2025 · 2 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
Thyroid function tests during substantial weight change Replied, post #46 · Clinical › Bloodwork · 30 Aug 2025 · 15 likes Thyroid function tests during substantial is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #59 · Evidence › Journal club · 30 Aug 2025 · 0 likes What I would want before treating STEP 4 as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #21 · Analytics › Method validation · 29 Aug 2025 · 0 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #59 · Practice › Side effects · 29 Aug 2025 · 16 likes Picking up post #58: that is the part I would want checked first. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have…
A parcel that arrived warm: a decision process, not a verdict Replied, post #11 · Practice › Storage & stability · 24 Aug 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The strength of…
Titles that describe the question, not the situation Replied, post #60 · Start Here › How to Ask · 30 Jul 2025 · 4 likes I changed my mind about titles after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 5 likes A definition problem is doing most of the work in this Nausea profile of amylin analogues discussion. Once the term is pinned down I suspect the disagreement mostly…
Coming back to: Official shortage notices and what they authorise Replied, post #43 · Access › Shortages · 29 Jun 2025 · 0 likes Post #39 describes the usual case. This is about the unusual one. Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to…
Repeatability versus intermediate precision Replied, post #43 · Analytics › Method validation · 23 Jun 2025 · 23 likes Adding a null result on repeatability versus intermediate precision. I looked, carefully, and found nothing, and null results deserve posting precisely because they…
Validating a calculator against hand arithmetic — what changed since Replied, post #92 · Data & Tools › Calculators · 26 May 2025 · 6 likes Picking up post #89: that is the part I would want checked first. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs…
Validating a calculator against hand arithmetic — what changed since Replied, post #71 · Data & Tools › Calculators · 16 May 2025 · 14 likes Everything in post #67 holds. The case it does not cover is the one I have. I would rather this thread reach "we do not know" about Validating a calculator against hand…
Coverage for the indication versus for the drug Replied, post #67 · Access › Insurance & coverage · 15 May 2025 · 0 likes Worth separating coverage as a question about the compound from coverage as a question about the documentation. They get answered by different people and only one of…
A page that has drifted out of date and needs a maintainer Replied, post #100 · Documentation › Wiki requests · 7 May 2025 · 5 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility…
Publishing an inconvenient result: a case study Replied, post #16 · Sourcing › Independent verification · 5 May 2025 · 12 likes Narrowing post #15, because the general version has more than one answer. I would be cautious about generalising from the publishing an inconvenient result example…
Titles that describe the question, not the situation Replied, post #6 · Start Here › How to Ask · 5 May 2025 · 16 likes Building on post #3 rather than restating it. Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question…
About the Meta-analyses category Replied, post #3 · Evidence › Meta-analyses · 3 May 2025 · 8 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #41 · Sourcing › Independent verification · 3 May 2025 · 24 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #40 · Compounds › Repair & healing peptides · 30 Apr 2025 · 13 likes Picking up post #38: that is the part I would want checked first. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one…
Metformin co-administration and additive GI effects Replied, post #14 · Practice › Interactions · 25 Apr 2025 · 0 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #42 · Evidence › Journal club · 19 Apr 2025 · 1 like Worth separating two things that post #40 runs together. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
Follow-up: Documentation that appears only after payment Replied, post #7 · Sourcing › Red flags · 19 Apr 2025 · 21 likes Documentation sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Certificates issued by the seller versus by a laboratory Replied, post #49 · Analytics › COA interpretation · 17 Apr 2025 · 27 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #39 · Compounds › Tirzepatide · 14 Apr 2025 · 17 likes This follows post #38 rather than contradicting it. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #125 · Compounds › Semaglutide · 10 Mar 2025 · 0 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #111 · Sourcing › Regulatory · 4 Mar 2025 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. I looked this up…
Consistent declarations and why they matter more than clever ones Replied, post #19 · Sourcing › Logistics · 11 Feb 2025 · 24 likes Adding the measurement that post #16 says would settle it. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not…
What we do not know about retatrutide, listed explicitly Replied, post #78 · Compounds › Retatrutide · 1 Feb 2025 · 9 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #41 · Sourcing › Red flags · 19 Jan 2025 · 0 likes That is a fair summary of where the discussion has got to.
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #53 · Compounds › Oral incretins · 15 Jan 2025 · 16 likes This follows post #50 rather than contradicting it. Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should…
Follow-up: Individual participant data versus aggregate data Replied, post #112 · Evidence › Meta-analyses · 12 Jan 2025 · 16 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
Follow-up: Individual participant data versus aggregate data Replied, post #14 · Evidence › Meta-analyses · 8 Jan 2025 · 5 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
UK access routes, dated and sourced — a second dataset Replied, post #24 · Regional › UK & Ireland · 7 Jan 2025 · 2 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
Oxidation pathways for methionine and tryptophan Replied, post #8 · Analytics › Impurities & related substances · 25 Dec 2024 · 2 likes Saving this. It is the version I will quote when the question comes round again.
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #84 · Compounds › Semaglutide · 24 Dec 2024 · 27 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Building a sensible monitoring schedule with your prescriber Replied, post #30 · Clinical › Bloodwork · 19 Dec 2024 · 0 likes One caution on building a sensible monitoring schedule: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real…
Washout with a one-week half-life: the arithmetic Replied, post #32 · Research Methods › N-of-1 designs · 28 Nov 2024 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #48 · Clinical › Special populations · 23 Nov 2024 · 0 likes Right, and stated more narrowly than I would have dared to state it.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #36 · Evidence › Journal club · 18 Nov 2024 · 0 likes Summarising the SURPASS-2 thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
Why "any advice?" is the least effective ending for a post Replied, post #43 · Start Here › How to Ask · 17 Nov 2024 · 18 likes Everything in post #41 holds. The case it does not cover is the one I have. Timeline questions need the timeline. Dates, in order, with what happened on each. "A while…
Revisiting: Moderation log format change Replied, post #28 · Meta › Announcements · 14 Nov 2024 · 0 likes Before the thread moves on from Moderation log format change — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted…
Why "any advice?" is the least effective ending for a post Replied, post #5 · Start Here › How to Ask · 2 Nov 2024 · 14 likes I read post #3 twice before replying, because I had assumed the opposite. If you are asking about a document, quote the exact wording of the line you are asking about.…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #130 · Clinical › Comorbidities · 29 Oct 2024 · 2 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Requesting a page: what makes a good request — what changed since Replied, post #127 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes Where I part company with post #123, and it is a narrow parting. Filing a mild objection to the consensus on Requesting a page. Mild because I might be wrong; an…
Progressive overload when the scale is falling — one year on Replied, post #20 · Nutrition & Training › Resistance training · 1 Sep 2024 · 0 likes The practical version of Progressive overload is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Reporting a discrepancy without making an allegation Replied, post #16 · Sourcing › Vendor reports · 5 Aug 2024 · 5 likes Something worth flagging about reporting a discrepancy: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…